Sulopenem etzadroxil

Sulopenem etzadroxil is an orally active prodrug of the antibiotic Sulopenem (HY-105284) . Sulopenem etzadroxil is active in mice infected with Bacillus anthracis[1][2][3].

Product Specifications

CAS Number

[1000296-70-7]

Product Name Alternative

PF-03709270

UNSPSC

12352005

Target

Antibiotic; Bacterial

Type

Reference compound

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/sulopenem-etzadroxil.html

Purity

98.66

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

O=C(C(N12)=C(S[C@@H](CC3)C[S@@]3=O)S[C@]2([H])[C@@H]([C@H](O)C)C1=O)OCOC(C(CC)CC)=O

Molecular Formula

C19H27NO7S3

Molecular Weight

477.62

References & Citations

[1]Bush K, et al. New β-lactam antibiotics and β-lactamase inhibitors. Expert opinion on therapeutic patents, 2010, 20 (10) : 1277-1293. |[2]Puttagunta S, et al. 1724. Murine Efficacy Studies of Sulopenem Against Bacillus anthracis[C]//Open Forum Infectious Diseases. US: Oxford University Press, 2022, 9 (Supplement_2) : ofac492. 1354. |[3]Zhanel GG, et al. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria. Drugs. 2022 Apr;82 (5) :533-557.